ONEMEDNET CORPORATION Deferred Federal Income Tax Expense (Benefit)
ONEMEDNET CORPORATION (ONMD) reported Deferred Federal Income Tax Expense (Benefit) of -$715.35 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2023-03-31
- ONEMEDNET CORPORATION deferred federal income tax expense (benefit) for fiscal 2022 was -$715.35K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 11 month | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2022-12-31 | -$715.35K 10-K · filed 2023-03-31 | |
| 2021-12-31 | -$118.53K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |